InMed Pharmaceuticals (INM) Debt to Equity (2021 - 2022)
InMed Pharmaceuticals (INM) reported Debt to Equity of $0.0 for Q1 2022, down 34.93% quarter-over-quarter from $0.0 in Q4 2021.
InMed Pharmaceuticals (INM) Debt to Equity (2021 - 2022) Analysis & Trends
InMed Pharmaceuticals has reported Debt to Equity for 2 years, with the latest figure at $0.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |